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To the Editor: Multidrug 
resistance in bacteria isolated from 
animals is an emerging phenomenon, 
mirroring what is happening among 
humans. During the past decade, 
expanded-spectrum β-lactamases in 
Enterobacteriaceae from humans 
(1) and animals (2) worldwide have 
been reported. Among humans, as a 
consequence of this high rate, use of 
carbepenems is increasing selection 
pressure; carbapenem-resistant gram-
negative organisms are increasingly 
reported, including carbapenemase-
producing Enterobacteriaceae and 
Acinetobacter spp. (3).
The most commonly acquired 
carbapenemases identifi ed in 
Acinetobacter spp. correspond to 
carbapenem-hydrolyzing class D 
β-lactamases (3). In particular, 
the worldwide spread of OXA-
23–producing A. baumannii is 
considered a serious threat; those 
strains are frequently involved in 
nosocomial outbreaks for which 
therapeutic options are extremely 
limited (3,4). Our study objective was 
to evaluate the possible occurrence 
of carbapenemase-producing gram-
negative bacteria in dairy cattle in 
France.
In August 2010, at a dairy farm 30 
km from Paris, France, rectal swabs 
were collected from 50 cows. Samples 
were precultured in buffered peptone 
water and incubated for 18 h at 37°C. 
Cultures were inoculated by streaking 
100 μL of the suspensions onto 
Drigalski agar plates (bioMérieux, 
Balmes-les-Grottes, France) con-
taining 1 μg/mL of imipenem to 
select for carbapenem-resistant gram-
negative isolates. Of the 50 samples, 
9 produced growth on imipenem-
containing plates. All colonies tested 
(10 colonies/sample) by using the 
API 20 NE (bioMérieux) system were 
fi rst identifi ed as A. lwoffi i. Molecular 
techniques based on sequencing of 
the gyrA, gyrB, and rpoB genes (5) 
enabled more precise identifi cation 
and indicated that all isolates belonged 
to the Acinetobacter genomospecies 
(DNA group) 15TU, which is known 
to be phylogenetically related to A. 
lwoffi i and which has been reportedly 
isolated from sewage, freshwater 
aquaculture habitats, trout intestines, 
and frozen shrimp (6).
One colony per sample was 
retained for further investigation 
(isolates BY1 to BY9). Susceptibility 
testing and MIC determinations were 
performed by disk-diffusion assay 
(Sanofi -Diagnostic Pasteur, Marnes-
la-Coquette, France) and Etest 
(AB bioMérieux, Solna, Sweden) 
(Table). All isolates except 1 were 
resistant to penicillins, combinations 
of penicillins and β-lactamase 
inhibitors, and carbapenems but 
susceptible to cefotaxime and of 
reduced susceptibility to ceftazidime. 
Isolate BY1 showed higher MICs 
for carbapenems (Table). In 
addition, all isolates were resistant 
to tetracycline, kanamycin, and 
fosfomycin and remained susceptible 
to fl uoroquinolones, chloramphenicol, 
gentamicin, amikacin, tobramycin, and 
sulfonamides. Susceptibility profi les 
of 3 Acinetobacter genomospecies 
15TU reference strains showed 
that they were fully susceptible to 
penicillins, carbapenems, tetracycline, 
and kanamycin.
Clonal diversity between the 
isolates was assessed by pulsed-
fi eld gel electrophoresis (5), which 
showed 6 distinct genotypes. Isolate 
BY1 corresponded to a single clone 
(data not shown), which indicated 
that the occurrence of Acinetobacter 
genomospecies 15TU strains among 
these animals was not the result of 
dissemination of a single clone.
PCR detection and sequencing 
of genes that encode carbapenem-
hydrolyzing class D β-lactamases 
(5) showed that the 9 Acinetobacter 
genomospecies 15TU isolates har-
bored a blaOXA-23 gene, whereas the 3 
reference strains remained negative. 
Sequencing confi rmed that all isolates 
expressed β-lactamase OXA-23, 
which is known to be widespread in 
A. baumannii.
Mating-out assays and plasmid 
electroporation assays were per-
formed by using blaOXA-23–positive 
Acinetobacter spp. isolates as donors 
and rifampin-resistant A. baumannii 
BM4547 isolates as a recipient strain 
(5); however, these assays were 
unsuccessful. Plasmid DNA analysis 
(5) gave uninterpretable results, with 
DNA degradations.
The genetic structures surrounding 
the blaOXA-23 gene were investigated by 
PCR mapping (7), which identifi ed 
transposon Tn2008 in isolate BY2 
only. Tn2008 is a major vehicle for 
the spread of the blaOXA-23 gene in A. 
baumannii in the People’s Republic 
of China (8) and the United States 
(9). In the other isolates, the ISAba1 
element of Tn2008 had been truncated 
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by a novel insertion sequence termed 
ISAcsp2 (www-is.biotoul.fr).
The dairy farmer indicated that 
most animals from which OXA-23 
producers had been identifi ed had 
received antimicrobial drugs in the 
previous weeks. Although 1 animal 
had received amoxicillin-clavulanate, 
most of the others had been given 
oxytetracycline and neomycin to treat 
mastitis.
β-lactamase OXA-23 is a 
common source of carbapenem 
resistance in A. baumannii (5). 
Infections with multidrug-resistant 
OXA-23–producing A. baumannii 
or A. junii have been reported 
from hospitals but not from the 
community. Our study showed that 
OXA-23–producers in particular, and 
carbapenemase producers in general, 
may be isolated from animals. Among 
the hypotheses that could explain 
the selection of this carbapenemase, 
use of penicillins or penicillin–β-
lactamase inhibitor combinations 
could create selective pressure for 
β-lactamases because OXA-23 does 
confer, in addition to decreased 
susceptibility to carbapenems, a 
high level of resistance to those 
compounds. We have previously 
shown that A. radioresistens, an 
environmental species, was the 
progenitor of the blaOXA-23 gene (10). 
Studies are needed to determine to 
what extent and at which locations 
Acinetobacter genomospecies 15TU 
and A. radioresistens might co-reside 
and therefore where the blaOXA-23 gene 
exchange might have occurred.
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Table. Antimicrobial drug MICs for Acinetobacter genomospecies 15TU isolates from cows and reference strains, France, August 2010* 
Drug class 
MIC, g/mL 
Acinetobacter genomospecies 15TU Reference strain 
BY1 BY2–BY9 NIPH 2171 NIPH 899 
Penicillins and combinations     
 Amoxicillin >256 128–256 4 4 
 Amoxicillin + CLA >256 128–256 4 4 
Cephalosporins     
 Cefoxitin 32 16–32 16 16 
 Cefotaxime 32 16–32 8 6 
 Ceftazidime 32 16–32 16 16 
 Cefepime 16 4–16 4 4 
Monobactam (aztreonam) 64 32 32 16 
Carbapenems     
 Meropenem 16 2–4 0.5 0.5 
 Imipenem >32 4–6 0.25 0.25 
 Doripenem 8 2–4 0.5 0.5 
Cyclines     
 Tetracycline >256 >256 0.5 0.5 
 Tigecycline 0.064 0.047–0.064 0.047 0.125 
Quinolones (ciprofloxacin) 0.5 0.5 0.25 0.25 
Aminoglycosides     
 Gentamicin 0.5 0.25–0.5 0.25 0.25 
 Kanamycin >256 >256 0.5 0.5 
Sulfonamides 4 4 4 >256 
*CLA, clavulanic acid (4 g/mL). 
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To the Editor: We collected 
Asian tiger mosquitoes, Aedes 
albopictus (Skuse), in Cancun in 
the Yucatan Peninsula of Mexico in 
September 2011. This mosquito is a 
nuisance biter of humans and a vector 
of numerous arboviruses, including 
those causing dengue, yellow fever, 
and chikungunya (1).
Ae. albopictus mosquitoes, which 
are native to Southeast Asia, emerged 
in the continental United States in 
1985 and thereafter spread rapidly 
across the southeastern United States 
and into northern Mexico (2,3). These 
mosquitoes have also been found in 
the states of Tamaulipas, Coahuila, 
and Nuevo Leon in northern Mexico, 
Chiapas in southern Mexico, and 
south of Mexico in Guatemala and 
Belize (3–9). These fi ndings are now 
complemented by our collection 
of Ae. albopictus mosquitoes from 
Cancun in Quintana Roo State, which 
with Yucatan and Campeche States 
compose the Yucatan Peninsula. A 
previous study of the mosquito fauna 
of Quintana Roo conducted in 2006 
did not report any Ae. albopictus 
mosquitoes (10).
During September 2011, Ae. 
albopictus mosquitoes were collected 
from a cemetery in Cancun, which 
is located in the eastern part of the 
Yucatan Peninsula (21°8.53′Ν, 
86°52.79′W) (Figure). The collection 
location was shaded by trees. Water 
in containers from which larvae were 
collected had an average temperature 
of 24.5°C and a pH of 8.5. The larval 
collection included ≈30 specimens of 
different developmental stages that 
were collected from vases and other 
artifi cial containers in the cemetery. 
The containers were examined as 
part of routine surveillance activities 
by Servicios Estatales de Salud de 
Quintana Roo. Larvae suspected 
to be those of Ae. albopictus 
mosquitoes were reared to adults for 
identifi cation, and a colony of Ae. 
albopictus mosquitoes from Cancun 
was established.
F0 or F1 adult specimens were 
confi rmed to be Ae. albopictus mos-
zquitoes by species identifi cation 
at Servicios Estatales de Salud de 
Quintana Roo (Quintana Roo, Mexico), 
Universidad Autónoma de Yucatan 
(Merida, Mexico), and Colorado State 
University (Fort Collins, CO, USA). 
The initial mosquito larval collection 
was composed of 26 Ae. albopictus, 3 
Ae. aegypti, and 1 Culex sp. In addition, 
6 Ae. albopictus female mosquitoes 
were collected from the cemetery by 
landing catches.
Finding Ae. albopictus mosquitoes 
in Cancun was not surprising because 
these mosquitoes have been found in 
nearby Belize (9). Cancun is also a 
major port for ships carrying tourists 
and goods that originate in areas to 
which Ae. albopictus mosquitoes 
are endemic, including Florida and 
Texas. Nevertheless, the introduction 
of Ae. albopictus mosquitoes into 
Cancun and the high potential for 
establishment and spread across the 
Yucatan Peninsula has major public 
health implications.
The Yucatan Peninsula is 
hyperendemic for dengue, with all 
4 dengue virus (DENV) serotypes 
circulating in this region. Should 
Ae. albopictus mosquitoes persist 
in this region, they may spread and 
come to play a secondary role to 
Ae. aegypti mosquitoes as local 
vectors of DENV. Ae. albopictus 
mosquitoes may also change local 
virus transmission dynamics. For 
example, DENV transmission may 
be intensifi ed in rural areas because 
Ae. albopictus mosquitoes are more 
likely than Ae. aegypti mosquitoes to 
be found in this setting. Ae. albopictus 
and Ae. aegypti mosquitoes also may 
differ in their potential for vertical 
transmission of DENV, which could 
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